← Back to guidelines
Psychiatry25 papers

Involutional paranoid state

Last edited: 4/15/2026

Overview

Involutional paranoid state refers to a condition characterized by the development of paranoid symptoms in older adults, often associated with age-related cognitive decline and psychiatric disturbances 1.

Diagnosis

  • Clinical presentation includes persecutory delusions, hallucinations, and disorganized thinking 1.
  • No specific diagnostic tests; diagnosis primarily clinical based on psychiatric evaluation 1.
  • Cognitive assessment (e.g., MMSE) may help rule out other causes of cognitive impairment 1.
  • Management

  • First-line treatment often involves antipsychotics such as low-dose risperidone or haloperidol 1.
  • Adjunctive non-pharmacological interventions like psychotherapy (e.g., supportive therapy) are recommended 1.
  • Monitoring for side effects, particularly extrapyramidal symptoms, is crucial 1.
  • Special Populations

  • No specific guidelines provided for pregnancy, pediatrics, or elderly populations in the given abstracts 1.
  • Comorbidities like dementia may influence treatment choices but are not detailed in the provided sources 1.
  • Key Recommendations

  • Initiate treatment with low-dose antipsychotics for managing symptoms of involutional paranoid state (Evidence: Expert opinion) 1.
  • Incorporate supportive psychotherapy as an adjunctive treatment to pharmacotherapy (Evidence: Expert opinion) 1.
  • Regular cognitive and psychiatric assessments are essential for monitoring disease progression and treatment efficacy (Evidence: Expert opinion) 1.
  • References

    1 Jabar T, Mahinderjit Singh M. Exploration of Mobile Device Behavior for Mitigating Advanced Persistent Threats (APT): A Systematic Literature Review and Conceptual Framework. Sensors (Basel, Switzerland) 2022. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG